Long-term efficacy and safety of rilpivirine plus abacavir and lamivudine in HIV-1 infected patients with undetectable viral load.

Autor: Galizzi, Nadia1,2 galizzi.nadia@hsr.it, Galli, Laura1, Poli, Andrea1, Gianotti, Nicola1, Carini, Elisabetta1, Bigoloni, Alba1, Tambussi, Giuseppe1, Nozza, Silvia1, Lazzarin, Adriano1,2, Castagna, Antonella1,2, Mancusi, Daniela3, Termini, Roberta3
Zdroj: PLoS ONE. 2/16/2018, Vol. 13 Issue 2, p1-10. 10p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje